ANMCO statement on the use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a practical guide for a streamlined implementation.
Di Fusco SA, Gronda E, Mocini E, Lucà F, Bisceglia I, De Luca L, Caldarola P, Cipriani M, Corda M, De Nardo A, Francese GM, Napoletano C, Navazio A, Riccio C, Roncon L, Tizzani E, Nardi F, Urbinati S, Valente S, Gulizia MM, Gabrielli D, Oliva F, Imperoli G, Colivicchi F.
Di Fusco SA, et al. Among authors: imperoli g.
Eur Heart J Suppl. 2022 May 18;24(Suppl C):C272-C277. doi: 10.1093/eurheartj/suac017. eCollection 2022 May.
Eur Heart J Suppl. 2022.
PMID: 35602255
Free PMC article.